[HTML][HTML] Current understanding of CTLA-4: from mechanism to autoimmune diseases
MM Hossen, Y Ma, Z Yin, Y Xia, J Du… - Frontiers in …, 2023 - frontiersin.org
Autoimmune diseases (ADs) are characterized by the production of autoreactive
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …
Current understanding of CTLA-4: from mechanism to autoimmune diseases.
MM Hossen, Y Ma, Z Yin, Y Xia, J Du… - Frontiers in …, 2023 - europepmc.org
Autoimmune diseases (ADs) are characterized by the production of autoreactive
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …
[HTML][HTML] Current understanding of CTLA-4: from mechanism to autoimmune diseases
MM Hossen, Y Ma, Z Yin, Y Xia, J Du… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Autoimmune diseases (ADs) are characterized by the production of autoreactive
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …
[PDF][PDF] Current understanding of CTLA-4: from mechanism to autoimmune diseases
MM Hossen, Y Ma, Z Yin, Y Xia, J Du, JY Huang… - 2023 - pdfs.semanticscholar.org
CTLA-4 is a T-cell co-receptor, also known as CD152. Compared to CD28, CTLA-4 has a
superior binding affinity with B7 family molecules, including CD80 and CD86 on antigen …
superior binding affinity with B7 family molecules, including CD80 and CD86 on antigen …
Current understanding of CTLA-4: from mechanism to autoimmune diseases
MM Hossen, Y Ma, Z Yin, Y Xia, J Du… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Autoimmune diseases (ADs) are characterized by the production of autoreactive
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …
lymphocytes, immune responses to self-antigens, and inflammation in related tissues and …
[PDF][PDF] Current understanding of CTLA-4: from mechanism to autoimmune diseases
MM Hossen, Y Ma, Z Yin, Y Xia, J Du, JY Huang… - 2023 - core.ac.uk
CTLA-4 is a T-cell co-receptor, also known as CD152. Compared to CD28, CTLA-4 has a
superior binding affinity with B7 family molecules, including CD80 and CD86 on antigen …
superior binding affinity with B7 family molecules, including CD80 and CD86 on antigen …
[PDF][PDF] Current understanding of CTLA-4: from mechanism to autoimmune diseases
MM Hossen, Y Ma, Z Yin, Y Xia, J Du, JY Huang… - 2023 - researchgate.net
CTLA-4 is a T-cell co-receptor, also known as CD152. Compared to CD28, CTLA-4 has a
superior binding affinity with B7 family molecules, including CD80 and CD86 on antigen …
superior binding affinity with B7 family molecules, including CD80 and CD86 on antigen …